Per Venge

Title: Per Venge: Innovator in Acute Kidney Injury Detection

Introduction

Per Venge is a notable inventor based in Sweden, recognized for his contributions to medical diagnostics. His work primarily focuses on methods for detecting acute kidney injury, which is crucial for timely and effective patient care.

Latest Patents

Per Venge has developed a patent titled "Methods, Devices And Kits For Detecting Or Monitoring Acute Kidney Injury." This patent outlines innovative methods for detecting acute kidney injury in individuals. The methods involve contacting a body fluid sample with an assay device that includes neutrophil gelatinase-associated lipocalin (NGAL) antibody and a detectable label. The process allows for the complexing of NGAL protein in the sample with the NGAL antibody. The amount of complex formed is then determined using the detectable label, providing a measure of acute kidney injury. Additionally, the methods include determining the origin of NGAL protein in a sample by assessing the relative amounts of monomeric, dimeric, and heterodimeric forms of NGAL protein. This advancement leads to improved diagnosis and better-targeted treatment.

Career Highlights

Per Venge is associated with Future Medical Diagnostics Co., Ltd., where he continues to innovate in the field of medical diagnostics. His work has the potential to significantly impact patient outcomes by enabling earlier detection and intervention for acute kidney injury.

Conclusion

Per Venge's contributions to the field of medical diagnostics, particularly in the detection of acute kidney injury, highlight his role as an important inventor. His innovative methods and dedication to improving patient care are commendable.